Jiangsu Apon Medical Technology Co., Ltd. engages in the research and development, production, and sale of medical devices for anesthesia and analgesia, nasal airway, and chronic pain management in China. It offers pain management services, such as high-precision intelligent microcomputer infusion pumps, wireless analgesia management systems, internal heat needle therapy devices, low-frequency therapy devices, and shockwave therapy devices; and iPainfree, a wireless analgesia management system software. The company also provides nasal and upper airway management solutions, including daily nasal care, perioperative care for nasal diseases, rhinitis diagnosis and treatment, snoring diagnosis and treatment, and allergy treatment; and sleep monitoring and improvement solutions. In addition, it is involved in research and development of digital diagnostic and treatment products for neurological diseases, cognitive training, and sleep monitoring; and research, development, production, and sale of medical devices comprising brain neuromodulation and intracranial implantable electrodes. Jiangsu Apon Medical Technology Co., Ltd. was founded in 2001 and is headquartered in Nantong, China.
Research context
Jiangsu Apon Medical Technology Co., Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Jiangsu Apon Medical Technology Co., Ltd is currently in a long term downtrend where the price is trading 9.7% below its 200 day moving average.
From a valuation standpoint, the stock is 5.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.1.
Jiangsu Apon Medical Technology Co., Ltd's total revenue sank by 7.3% to $110M since the same quarter in the previous year.
Its net income has dropped by 5.8% to $25M since the same quarter in the previous year.
Finally, its free cash flow fell by 69.0% to $19M since the same quarter in the previous year.
Based on the above factors, Jiangsu Apon Medical Technology Co., Ltd gets an overall score of 1/5.